MucoLife Therapeutics
MucoLife Therapeutics is a biotech company developing first-in-class therapies targeting pathological mucus obstruction in chronic respiratory diseases such as COPD, cystic fibrosis, and bronchiectasis.
MucoLife Therapeutics is a biotech company developing first-in-class therapies targeting pathological mucus obstruction in chronic respiratory diseases such as COPD, cystic fibrosis, and bronchiectasis.
Extem Pharma, a pioneering pharmaceutical company based in Uppsala, is dedicated to revolutionizing healthcare through cutting-edge research and development.
Medicago PharmaTech is a contract manufacturing organization well-equipped to aid developing companies in the life science industry as a manufacturing partner. Offering an attractive combination of manufacturing at industrial scale production capacity with agile performance to ensure expedient startup and changeover to the contract partner.
Vivesto is a research and development company that develops new treatment options for patients suffering from difficult-to-treat cancer.
Fluicell is an innovative life science company dedicated to delivering single-cell microfluidic research tools and services for scientists worldwide, based in Gothenburg Sweden.
One-carbon Therapeutics AB is a clinical-stage biotechnology company headquartered in Sweden, pioneering novel anti-cancer therapies. Their most advanced candidate - TH9619 - has started clinical development in 2025.
FINGERS Brain Health Institute is a Swedish non-profit foundation driven to advance research on healthy brain aging and the implementation of dementia prevention.
QPS is a GLP/GCP-compliant clinical research organization (CRO) delivering the highest grade of discovery, preclinical, and clinical drug development services.